Gene · 1871
Papers3,808
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,808
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcriptome Sequencing of lncRNAs, circRNAs, miRNAs, mRNAs, and Interaction Network Constructing in Acute Exacerbation of Idiopathic Pulmonary Fibrosis. | Discov Med | 2023 | 37811627 | PubTator, text mining | PubMed |
| The m6A reader YTHDC1-mediated lncRNA CTBP1-AS2 m6A modification accelerates cholangiocarcinoma progression. | Heliyon | 2023 | 37809459 | PubTator, text mining | PubMed |
| A Novel Gene Pair CSTF2/DPE2A Impacts Prognosis and Cell Cycle of Hepatocellular Carcinoma. | J Hepatocell Carcinoma | 2023 | 37791068 | PubTator, text mining | PubMed |
| The pivotal role of EMT-related noncoding RNAs regulatory axes in hepatocellular carcinoma. | Front Pharmacol | 2023 | 37767397 | PubTator, text mining | PubMed |
| Regulatory T cells are associated with the tumor immune microenvironment and immunotherapy response in triple-negative breast cancer. | Front Immunol | 2023 | 37767092 | PubTator, text mining | PubMed |
| Thymoquinone Potentially Modulates the Expression of Key Onco- and Tumor Suppressor miRNAs in Prostate and Colon Cancer Cell Lines: Insights from PC3 and HCT-15 Cells. | Genes (Basel) | 2023 | 37761870 | PubTator, text mining | PubMed |
| G1 Dynamics at the Crossroads of Pluripotency and Cancer. | Cancers (Basel) | 2023 | 37760529 | PubTator, text mining | PubMed |
| Screening and validation of novel serum panel of microRNA in stratification of prostate cancer. | Prostate Int | 2023 | 37745909 | PubTator, text mining | PubMed |
| LncRNA AC142119.1 facilitates the progression of neuroblastoma by epigenetically initiating the transcription of MYCN. | J Transl Med | 2023 | 37741985 | PubTator, text mining | PubMed |
| Novel Insights into Circular RNAs in Metastasis in Breast Cancer: An Update. | Noncoding RNA | 2023 | 37736901 | PubTator, text mining | PubMed |
| Signaling-induced systematic repression of miRNAs uncovers cancer vulnerabilities and targeted therapy sensitivity. | Cell Rep Med | 2023 | 37734378 | PubTator, text mining | PubMed |
| Long non-coding RNA AC099850.4 correlates with advanced disease state and predicts worse prognosis in triple-negative breast cancer. | Front Med (Lausanne) | 2023 | 37727755 | PubTator, text mining | PubMed |
| Key role of exosomes derived from M2 macrophages in maintaining cancer cell stemness (Review). | Int J Oncol | 2023 | 37711063 | PubTator, text mining | PubMed |
| LncRNA THUMPD3-AS1 promotes invasion and EMT in gastric cancer by regulating the miR-1297/BCAT1 pathway. | iScience | 2023 | 37705956 | PubTator, text mining | PubMed |
| Global impact of somatic structural variation on the cancer proteome. | Nat Commun | 2023 | 37704602 | PubTator, text mining | PubMed |
| Nucleosome repositioning in chronic lymphocytic leukemia. | Genome Res | 2023 | 37699659 | PubTator, text mining | PubMed |
| Identification of metabolic biomarkers associated with nonalcoholic fatty liver disease. | Lipids Health Dis | 2023 | 37697333 | PubTator, text mining | PubMed |
| Integrated bioinformatics analysis of noncoding RNAs with tumor immune microenvironment in gastric cancer. | Sci Rep | 2023 | 37696973 | PubTator, text mining | PubMed |
| Various LncRNA Mechanisms in Gene Regulation Involving miRNAs or RNA-Binding Proteins in Non-Small-Cell Lung Cancer: Main Signaling Pathways and Networks. | Int J Mol Sci | 2023 | 37686426 | PubTator, text mining | PubMed |
| MiRNAs in Lung Adenocarcinoma: Role, Diagnosis, Prognosis, and Therapy. | Int J Mol Sci | 2023 | 37686110 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1871/papers?page=10